hitcounter
This site is an rss/xml news reader containing our favorite feeds. All articles are the copyrighted material of the blogs that wrote them.

Lapatinib In The Treatment Of Breast Cancer

Based on the unanimous recommendation of an Independent Data Monitoring Committee (IDMC), GlaxoSmithKline announced that it has halted enrollment in its Phase III clinical trial evaluating the combination of Tykerb (lapatinib ditosylate) and capecitabine (Xeloda(R)) versus capecitabine alone........

Read The Full Article:
http://www.drilltools.org/256


Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!
Website designed by Bartosz Brzezinski
Powered by blogdig.net